Skip to main content

Inogen Inc

INGN
Exchange
Nasdaq
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001294133

No open-market purchases or sales by Inogen Inc insiders were filed in the last 90 days; 129 institutions reported holding it in 13F filings for Q2 2026, worth $124.3M in total; no superinvestor holds it.

Q4 2022 vs. Q3 2022

How the institutions holding Inogen Inc changed between Q3 2022 and Q4 2022.

All holders in Q4 2022All holders in Q3 2022

13F holders of INGN: Q3 2022 compared with Q4 2022
MeasureQ3 2022Of which not filed for Q4 2022Q4 2022Change
Holders1451135−9
Shares22.1M20021.5M−610.1K (−2.8%)
Value$537.7M$4.86K$424.6M−$113.1M (−21.0%)

1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.

New holders (12)

Institutions that held Inogen Inc at the end of Q4 2022 but not at the end of Q3 2022.

Institutions new to INGN in Q4 2022
InstitutionSharesValue% of portfolio
Bridgeway Capital Management, LLC113,500$2.24M0.06%
Engineers Gate Manager LP38,522$759.3K0.05%
Squarepoint Ops LLC33,936$668.9K0.00%
Trexquant Investment LP23,645$466.0K0.01%
Occudo Quantitative Strategies LP13,391$263.9K0.03%
Jane Street Group, LLC11,134$219.5K0.00%
Acadian Asset Management LLC3,523$69.0K0.00%
Simplex Trading, LLC567$11.0K0.00%
Madden Securities Corp500$9.86K0.01%
Belpointe Asset Management LLC102$2.00K0.00%
Parkside Financial Bank & Trust86$1.70K0.00%
Glassman Wealth Services31$6110.00%

Sold out (21)

Institutions that held Inogen Inc at the end of Q3 2022 and filed for Q4 2022 without it.

Not filed for Q4 2022 yet (1)

Institutions that held Inogen Inc at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding INGN in Q3 2022 that haven't filed for Q4 2022
InstitutionShares, Q3 2022Value, Q3 2022
American Portfolios Advisors200$4.86K